If you’re developing healthcare technology today, one of the most important questions you can ask yourself isn’t whether your innovation works—it’s whether you’re thinking too small. That may sound surprising, especially if you’ve spent years developing a technology, validating it, protecting it, and refining its commercial potential.
Most innovators become deeply focused on the first application they identify because that’s where the journey began. They see a problem, develop a solution, and naturally concentrate on bringing that solution to market. The challenge is that some of the most valuable healthcare technologies in history generated far more value from their second, third, fourth, and fifth applications than they did from the original market they were designed to serve.
If you’re evaluating the licensing potential of your technology, that distinction matters. One of the biggest opportunities in healthcare today involves platform technologies—innovations capable of supporting multiple products, multiple markets, and multiple licensing opportunities. If you’re only looking at one application for your technology, there’s a good chance you’re leaving significant value on the table.
What Gore Can Teach You About Platform Thinking
Most people know W. L. Gore & Associates because of Gore-Tex. The waterproof, breathable material became a household name and transformed multiple consumer markets. What many people don’t realize, however, is that Gore built an equally impressive healthcare business by applying its material science expertise to entirely different challenges.
The company’s advanced materials eventually found applications in vascular grafts, surgical meshes, cardiovascular devices, and numerous implantable medical technologies. The underlying technology platform remained largely the same; what changed were the applications. That distinction highlights how platform technologies create value. The value wasn’t limited to a single product—it came from the ability to apply a core capability across multiple markets.
If you’re developing healthcare technology today, take a moment to think about your own innovation. Are you focused on a product, or are you sitting on a platform? The answer could dramatically influence the value of your licensing opportunity.
The Difference Between a Product and a Platform
A product solves a specific problem. A platform solves a category of problems. That may sound like a subtle distinction, but it fundamentally changes how you evaluate commercialization opportunities.
Consider a new sensor technology. You could develop a single monitoring device around that sensor and pursue one market opportunity, or you could evaluate whether the same sensor technology could support cardiovascular monitoring, respiratory monitoring, remote patient monitoring, wearable health devices, rehabilitation applications, and home healthcare solutions. The underlying technology hasn’t changed—the opportunity has.
At Licensing Consulting Group, we’ve found that innovators often become so focused on the first application they identify that they never fully evaluate where else the technology could create value. In many cases, potential licensees see opportunities that the innovator hasn’t even considered. That’s why platform thinking is so important. The opportunity may not be where you think it is.
Why Healthcare Companies Love Platform Technologies
Healthcare companies face many of the same challenges we’ve discussed throughout this series. They need to reduce risk, accelerate development timelines, improve outcomes, and identify new sources of growth. Platform technologies help accomplish all of those objectives because they offer more than a single product opportunity—they provide a capability that can generate multiple future opportunities.
Consider CRISPR technology. When CRISPR first emerged, many people viewed it simply as a tool for gene editing. Today, healthcare companies, pharmaceutical organizations, research institutions, and biotechnology firms continue exploring applications that extend far beyond the original use cases. The platform created opportunities across multiple industries because the underlying capability could be adapted to solve a wide range of problems.
The same principle applies throughout healthcare. Artificial intelligence platforms, advanced materials, sensor technologies, diagnostic systems, drug delivery platforms, imaging technologies, and digital health infrastructures often create far more value through multiple applications than they do through a single product. If you’re developing technology today, the question isn’t simply whether someone would license your innovation—it’s how many licensing opportunities your innovation could potentially support.
Learn How MedTech Companies Evaluate Platform Technologies
If you’re trying to determine whether your healthcare innovation has platform potential, understanding how healthcare companies evaluate licensing opportunities can help you identify value that may not be immediately obvious.
Watch the free replay of the MedTech Licensing Workshop:
https://licensingconsultinggroup.com/workshops/med-tech-licensing-workshop/
You’ll learn how MedTech companies assess technologies, evaluate commercialization opportunities, and determine where innovation fits within their long-term growth strategies.
The Healthcare Industry Is Filled With Platform Success Stories
One reason platform technologies are so valuable is that healthcare innovation rarely follows a straight line. Consider Intuitive Surgical. Most people associate the company with robotic-assisted surgery, but the value extends far beyond a single surgical system. The underlying platform combines robotics, visualization, software, instrumentation, data collection, and surgeon training capabilities that continue expanding into new procedures, specialties, and healthcare applications.
The original application generated tremendous value, but the broader platform opportunity has enabled growth across multiple surgical disciplines and technology ecosystems. The same pattern can be seen in remote monitoring technologies, wearable sensors, diagnostic platforms, and artificial intelligence applications. Once a technology proves it can reliably collect, analyze, or improve healthcare information, additional opportunities often emerge. If you’re evaluating your own technology, it’s worth asking whether the first application you’ve identified is merely the starting point rather than the destination.
Licensing Reality Check
One of the most common mistakes we see at Licensing Consulting Group is innovators assuming their first application is their only application. That assumption can dramatically limit licensing opportunities because companies don’t necessarily license technologies based solely on what they do today—they often license technologies because of what they could do tomorrow.
If you’re presenting your innovation as a single product opportunity, you may be overlooking the broader platform story that makes the opportunity attractive to potential licensees. This doesn’t mean every technology is a platform, but it does mean every technology deserves a broader evaluation before you narrow your focus. The goal is to determine whether your innovation solves one problem or creates a capability that can solve many.
Looking Beyond Your Original Market
One of the most valuable exercises you can perform is to temporarily forget the market you originally had in mind and instead focus on the capability your technology provides. Ask yourself what it improves, measures, accelerates, simplifies, or reduces. Once you identify that core capability, begin looking for adjacent markets where it creates value.
This is where many of the most successful licensing strategies originate. A technology developed for remote patient monitoring may create opportunities in sports performance, rehabilitation, elder care, occupational health, or consumer wellness. A material developed for wound care may create opportunities in surgical products, medical textiles, implantable devices, or healthcare wearables. A software platform developed for one healthcare specialty may find applications across multiple clinical disciplines. The more broadly you evaluate the capability, the more opportunities you may uncover.
Building a Licensing Portfolio Instead of a Single Deal
Most innovators think about licensing as a single transaction, but platform technologies often require a different perspective. Instead of asking how to secure one licensing agreement, you may need to think about how to create a licensing portfolio.
Different applications may require different licensees, different industries may require different expertise, and different markets may have different commercialization timelines. A platform technology can often support multiple licensing relationships simultaneously if structured properly. That doesn’t mean every opportunity should be pursued at once; it means understanding the full landscape before deciding where to focus your efforts. The stronger your understanding of the platform, the stronger your licensing strategy becomes.
Your Technology May Be Bigger Than Your Original Vision
Many successful healthcare technologies became more valuable after innovators stopped viewing them as products and started viewing them as platforms. The original application created the opportunity, but the platform created the long-term value.
If you’re developing healthcare technology today, ask yourself whether you’re evaluating your innovation based on what it is or based on what it could become. The answer may reveal opportunities you haven’t yet considered, and those opportunities may ultimately be more valuable than the market that first inspired the technology.
Ready to Evaluate the Full Licensing Potential of Your Technology?
If you’re developing a healthcare innovation, identifying platform opportunities may be one of the most important steps in maximizing its commercial value.
At Licensing Consulting Group, we help innovators evaluate technologies from a broader strategic perspective, identify adjacent market opportunities, assess licensing potential across multiple industries, develop commercialization strategies, and connect with organizations that can help bring those opportunities to market. Many innovators focus on a single application because it’s familiar. Our role is often to help uncover additional opportunities, identify potential licensing partners, and develop licensing strategies that align with both short-term objectives and long-term value creation.
If you’d like help evaluating whether your technology has platform potential and exploring licensing opportunities across multiple markets, schedule a consultation to discuss your commercialization objectives and strategic options.
Stay Connected
If you enjoy practical insights on licensing strategy, commercialization, and intellectual property opportunities, subscribe to the Licensing Consulting Group newsletter:
https://licensingconsultinggroup.com/newsletter/
You’ll receive articles, licensing insights, market trends, and real-world commercialization strategies designed to help you maximize the value of your intellectual property.
About Licensing Consulting Group
Licensing Consulting Group helps innovators, entrepreneurs, startups, and established companies identify licensing opportunities, develop commercialization strategies, connect with prospective licensing partners, and negotiate licensing agreements across a wide range of industries, including medical technology, healthcare, software, consumer products, industrial technologies, and advanced materials.
Rand Brenner is an IP professional whose passion is helping inventors, startups, and businesses use licensing to turn their IP into income-producing products, services, and technologies. His decades of experience run the gamut from medical devices to food technology to consumer products. He’s licensed some of the biggest Hollywood entertainment blockbusters, including the Batman Movies (1 and 2) and the number one kid’s action TV show, the Mighty Morphin Power Rangers. Rand speaks about licensing and is a featured speaker at investment conferences, trade shows, colleges, and startup events. His first book, Hidden Wealth: The Money-Making Power of Licensing, was released in 2019 and is available on Amazon.com. He’s also a published writer, and his articles have appeared in several prestigious trade magazines, including The Licensing Journal, Intellectual Property Magazine, and License India.
Working Through a Licensing or Commercialization Challenge?
If you have market-ready intellectual property, a licensing campaign that has stalled, or a business opportunity that may benefit from licensing, a short strategy discussion can help clarify the next step.